Clinical Trials Logo

Generalized Tonic Clonic Seizure clinical trials

View clinical trials related to Generalized Tonic Clonic Seizure.

Filter by:
  • None
  • Page 1

NCT ID: NCT05147571 Active, not recruiting - Epilepsy Clinical Trials

RNS System NAUTILUS Study

NAUTILUS
Start date: August 9, 2022
Phase: Phase 3
Study type: Interventional

To demonstrate that the RNS System for thalamic stimulation is safe and effective as an adjunctive therapy for the reduction of primary generalized seizures in individuals 12 years of age or older who have drug-resistant idiopathic generalized epilepsy.

NCT ID: NCT05064878 Recruiting - Clinical trials for CDKL5 Deficiency Disorder

A Study to Investigate the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder

Start date: March 8, 2022
Phase: Phase 3
Study type: Interventional

This is a multicenter, double-blind, parallel-group, placebo controlled, 2-part study to evaluate the efficacy and safety of ZX008 when used as adjunctive therapy for the treatment of uncontrolled seizures in children and adults with cyclin-dependent kinase like-5 (CDKL5) deficiency disorder (CDD).

NCT ID: NCT03443388 Completed - Clinical trials for Drug Resistant Epilepsy

Novel Helmet Design in Patients With Seizures

Start date: August 14, 2017
Phase: N/A
Study type: Interventional

This is a two-part study that aims to determine the reliability and safety of the use of the Hövding inflatable helmet in seizures, as evidenced by the deployment of the helmet during seizures, and qualitative patient reporting.